2013 Opioid Maintenance Pharmacotherapy: A Course for Clinicians

Sunday, November 10, 2013
8:00 a.m. – 5:30 p.m.

Trusandra Taylor, MD, JEVS Human Services, Philadelphia, PA
Susan Neshin, MD, JSAS Healthcare, Inc., Neptune, NJ
Laura McNicholas, MD, Philadelphia Veterans Administration Medical Center, Philadelphia, PA
Abigail Kay, MD, Thomas Jefferson University, Philadelphia, PA
Laura Murray, DO, NHS Human Services, Philadelphia, PA


This course is recommended for clinicians who have an interest in increasing their knowledge of medication assisted treatment (MAT) of opioid dependence. The updated curriculum includes current consensus guidelines for best practice treatment for opioid addiction, focusing primarily on the utilization of methadone.

Topics include overview of opioid dependence, epidemiology, opioid pharmacology, evidence-based treatment options, patient assessment/selection, special populations, induction and maintenance protocols, pain management, drug-to-drug interactions, adverse effects, methadone deaths, managing medical/psychiatric problems, drug testing, regulatory issues, an accreditation update, risk management and an overview of other medication modalities.

While the course is primarily intended for clinicians with limited experience in MAT, it also provides updated information for more experienced clinicians. Participants will receive a comprehensive syllabus with reference and resource materials. To further integrate the educational objectives, participants are encouraged to discuss challenging problems and clinical issues to facilitate understanding of didactic principles.

Experienced opioid treatment program medical directors will conduct the program, focusing on the goal for participants to acquire the essential knowledge and skills necessary to deliver safe and effective medication assisted treatment for patients with opioid dependence.

The $225.00 registration fee includes a morning coffee service and afternoon luncheon.


Sponsored by the American Association for the Treatment of Opioid Dependence, Inc. (AATOD)

Share This